<?xml version="1.0" encoding="iso-8859-1"?>
<!-- generator="FeedCreator 1.7.2" -->
<rss version="2.0">
    <channel>
        <title>TGen TCRS Clinical Trials via MedWorm.com</title>
        <description>MedWorm.com provides a medical RSS filtering service. Over 6000 RSS medical sources are combined and output via different filters. This feed contains the latest items from the 'TGen TCRS Clinical Trials' source.</description>
        <link><![CDATA[http://www.medworm.com/rss/search.php?qu=TGen+TCRS+Clinical+Trials&t=TGen+TCRS+Clinical+Trials&s=Search&f=source]]></link>
        <lastBuildDate>Sat, 18 Jun 2011 16:24:10 +0100</lastBuildDate>
        <item>
            <title>An Open Label, multi-center, single arm study of pasireotide LAR in patients with rare tumors of the neuroendocrine origin</title>
            <link>http://www.medworm.com/index.php?rid=4709992&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, NEUROENDOCRINE. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4709992</comments>
            <pubDate>Thu, 14 Apr 2011 14:48:57 +0100</pubDate>
            <guid isPermaLink="false">4709992</guid>        </item>
        <item>
            <title>A Phase I, Multi-center, Open-Label, Dose Escalation, Safety, Pharmacodynamic Study of GO-203-2c given intravenously Daily x21 in Patients with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=4710008&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4710008</comments>
            <pubDate>Wed, 13 Apr 2011 17:20:00 +0100</pubDate>
            <guid isPermaLink="false">4710008</guid>        </item>
        <item>
            <title>An open-label, Phase 1, Dose-Escalation Study evaluating the safety and tolerability of GDC-0032 in Patients with Locally Advanced or Metastatic Tumors</title>
            <link>http://www.medworm.com/index.php?rid=4710007&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4710007</comments>
            <pubDate>Wed, 13 Apr 2011 17:20:00 +0100</pubDate>
            <guid isPermaLink="false">4710007</guid>        </item>
        <item>
            <title>A Phase 1, Open Label, Dose- Finding study evaluating the safety and Pharmacokinetics of HBI-8000 in patients with Advanced Solid Tumors or Relapsed or Refractory Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=4710005&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4710005</comments>
            <pubDate>Wed, 13 Apr 2011 17:20:00 +0100</pubDate>
            <guid isPermaLink="false">4710005</guid>        </item>
        <item>
            <title>A randomized, open-label, multi-center, phase I, crossover study to assess the relative bioavailability of 2 oral formulations of TKI258 (CSF capsule vs. FMI tablet), and the effect of food on the bioavailability of TKI258, in patients with advanced solid tumors</title>
            <link>http://www.medworm.com/index.php?rid=4710004&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (website pending) (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4710004</comments>
            <pubDate>Wed, 13 Apr 2011 17:20:00 +0100</pubDate>
            <guid isPermaLink="false">4710004</guid>        </item>
        <item>
            <title>A Dose-Escalation Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamins of Intravenous Infusion of VX15/2503 in Adult Patients with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=4710002&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4710002</comments>
            <pubDate>Wed, 13 Apr 2011 17:20:00 +0100</pubDate>
            <guid isPermaLink="false">4710002</guid>        </item>
        <item>
            <title>A Phase 2, Double-Blind, Placebo-Controlled Study Evaluating the Safety and Efficacy of IPI-926 in Patients with Metastatic or Locally Advanced (Unresectable) Chondrosarcoma</title>
            <link>http://www.medworm.com/index.php?rid=4709991&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, CHONDROSARCOMA. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4709991</comments>
            <pubDate>Wed, 13 Apr 2011 17:20:00 +0100</pubDate>
            <guid isPermaLink="false">4709991</guid>        </item>
        <item>
            <title>A Phase 1 Dose Escalation Study of NMS-1286937 Administered to Adult Patients with Advanced/Metastatic Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=4710006&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4710006</comments>
            <pubDate>Mon, 27 Dec 2010 20:20:00 +0100</pubDate>
            <guid isPermaLink="false">4710006</guid>        </item>
        <item>
            <title>A Multi-Center, Open Label, Phase I Dose-Escalation Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Intravenous ALN-VSP02 in Patients with Advanced Solid Tumors with Liver Involvement</title>
            <link>http://www.medworm.com/index.php?rid=4709993&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4709993</comments>
            <pubDate>Mon, 27 Dec 2010 20:20:00 +0100</pubDate>
            <guid isPermaLink="false">4709993</guid>        </item>
        <item>
            <title>A Phase 1 Dose Escalation Study to Determine the Safety, Pharmacokinetics and Pharmacodynamics of Intravenous TKM-080301 in Patients with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=4710003&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (website pending) (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4710003</comments>
            <pubDate>Mon, 20 Dec 2010 20:20:00 +0100</pubDate>
            <guid isPermaLink="false">4710003</guid>        </item>
        <item>
            <title>A Phase 1b, Open-Label, Dose-Escalating Trial of Tivozanib (AV-951) in Combination with Capecitabine (Xeloda®) in Subjects with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=4710001&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (website pending) (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4710001</comments>
            <pubDate>Mon, 20 Dec 2010 20:20:00 +0100</pubDate>
            <guid isPermaLink="false">4710001</guid>        </item>
        <item>
            <title>A Phase I, Multicenter, Open-Label, Dose-Escalation, Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) with Initial Dexamethasone Premedication Given Intravenously to Patients with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=4710000&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4710000</comments>
            <pubDate>Mon, 20 Dec 2010 20:20:00 +0100</pubDate>
            <guid isPermaLink="false">4710000</guid>        </item>
        <item>
            <title>A Phase 1 Study of NKTR-102 (PEG-Irinotecan) in Combination with 5-Fluorouracil and Leucovorin (FULPIRI) in Patients with Advanced Cancer</title>
            <link>http://www.medworm.com/index.php?rid=4709999&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (website pending) (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4709999</comments>
            <pubDate>Mon, 20 Dec 2010 20:20:00 +0100</pubDate>
            <guid isPermaLink="false">4709999</guid>        </item>
        <item>
            <title>A Phase I Dose-Escalation Study of LY2940680 in patients with Advanced Cancer</title>
            <link>http://www.medworm.com/index.php?rid=4709998&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4709998</comments>
            <pubDate>Mon, 20 Dec 2010 20:20:00 +0100</pubDate>
            <guid isPermaLink="false">4709998</guid>        </item>
        <item>
            <title>A Phase 1/2, First in Human, Single-arm, Open-label Study of Once a Day, Orally Administered BMN 673 in Patients with Advanced or Recurrent Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=4709997&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...(website pending) (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4709997</comments>
            <pubDate>Mon, 20 Dec 2010 20:20:00 +0100</pubDate>
            <guid isPermaLink="false">4709997</guid>        </item>
        <item>
            <title>A Phase 1 open label, saftey, pharmacokinetic and pharmacodynamic dose escalation study of BIND-014, given by IV infusion to patients with advanced or metastatic cancer</title>
            <link>http://www.medworm.com/index.php?rid=4709996&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types...(website pending) (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4709996</comments>
            <pubDate>Mon, 20 Dec 2010 20:20:00 +0100</pubDate>
            <guid isPermaLink="false">4709996</guid>        </item>
        <item>
            <title>An open-label, Phase I, dose-escalation study to characterize the safety, tolerability, pharmacokinetics, and maximum tolerated dose of BAY 1000394 given in a 4-week on / 2-week off schedule in subjects with advanced malignancies</title>
            <link>http://www.medworm.com/index.php?rid=4709995&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4709995</comments>
            <pubDate>Mon, 20 Dec 2010 20:20:00 +0100</pubDate>
            <guid isPermaLink="false">4709995</guid>        </item>
        <item>
            <title>An open label Phase I dose escalation study to evaluate the safety, tolerability, pharmacokinetics, maximum tolerated dose and biomarker response after intravenous administration of weekly BAY 80-6946 to patients with advanced cancer</title>
            <link>http://www.medworm.com/index.php?rid=4709994&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4709994</comments>
            <pubDate>Mon, 20 Dec 2010 20:20:00 +0100</pubDate>
            <guid isPermaLink="false">4709994</guid>        </item>
        <item>
            <title>A Phase 1, Open-Label, Dose-Finding Study Evaluating the Safety and Pharmacokinetics of HBI-8000 in Patients with Advanced Solid Tumors or Relapsed or Refractory Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=4305318&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, LYMPHOMA. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (website pending) (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=4305318</comments>
            <pubDate>Mon, 20 Dec 2010 20:20:00 +0100</pubDate>
            <guid isPermaLink="false">4305318</guid>        </item>
        <item>
            <title>A Phase I, Multicenter, Open-Label, Dose-Escalation, Safety, Tolerability, Pharmacodynamic and Pharmacokinetic Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) with Initial</title>
            <link>http://www.medworm.com/index.php?rid=3796115&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3796115</comments>
            <pubDate>Wed, 28 Jul 2010 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">3796115</guid>        </item>
        <item>
            <title>A Phase I, Open-Label, Dose Escalation Study of ASG-5ME in Patients with Pancreatic Adenocarcinoma</title>
            <link>http://www.medworm.com/index.php?rid=3796114&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, PANCREATIC CANCER. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3796114</comments>
            <pubDate>Wed, 28 Jul 2010 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">3796114</guid>        </item>
        <item>
            <title>A Single Arm Open Label Expanded Access Study of GDC-0449 in Patients with Locally Advanced or Metastatic Basal Cell Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=3796113&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, BASAL CELL CARCINOMA. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3796113</comments>
            <pubDate>Wed, 28 Jul 2010 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">3796113</guid>        </item>
        <item>
            <title>A Phase I Trial of Oral PX-478 (a HIF-1 Inhibitor) in Patients with Advanced Solid Tumors or Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=3553584&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3553584</comments>
            <pubDate>Fri, 07 May 2010 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">3553584</guid>        </item>
        <item>
            <title>An International, Randomized, Double-blinded, Phase III Efficacy Study of XL184 versus Placebo in Subjects with Unresectable, Locally Advanced, or Metastatic Medullary Thyroid Cancer</title>
            <link>http://www.medworm.com/index.php?rid=3553583&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, THYROID – MEDULLARY. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3553583</comments>
            <pubDate>Fri, 07 May 2010 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">3553583</guid>        </item>
        <item>
            <title>A Phase I, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynmaic Study of E6201 Administered Once Weekly for 3 Weeks (days 1, 8, and 15 of a 28-day Cycle) in Subjects with Melanoma</title>
            <link>http://www.medworm.com/index.php?rid=3553582&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3553582</comments>
            <pubDate>Fri, 07 May 2010 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">3553582</guid>        </item>
        <item>
            <title>A Randomized, Double-blind, Placebo-controlled, Phase III Study of OSI-906 in Patients with Locally Advanced or Metastatic Adrenocortical Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=3553581&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, ADRENOCORTICAL CARCINOMA. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3553581</comments>
            <pubDate>Fri, 07 May 2010 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">3553581</guid>        </item>
        <item>
            <title>A Phase 1 open labeled dose escalation study of VELIPARIB in combination with FOLFIRI in subjects with advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=3391667&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3391667</comments>
            <pubDate>Mon, 22 Mar 2010 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">3391667</guid>        </item>
        <item>
            <title>A Dose Escalation Study Evaluating MK-1775 in Both Monotherapy and in combination with Cisplatin in Adult Patients with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=3391666&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3391666</comments>
            <pubDate>Mon, 22 Mar 2010 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">3391666</guid>        </item>
        <item>
            <title>A Phase 1b/2a Safety and Pharmacokinetic Study of IT-101 in the Treatment of Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=3391665&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, SOLID TUMORS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3391665</comments>
            <pubDate>Mon, 22 Mar 2010 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">3391665</guid>        </item>
        <item>
            <title>A Phase I Dose-Escalation Study of Brutons Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Recurrent B Cell Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=3391664&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, LYMPHOMA. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3391664</comments>
            <pubDate>Mon, 22 Mar 2010 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">3391664</guid>        </item>
        <item>
            <title>A Pilot Study Utilizing Molecular Profiling by IHC, FISH, DNA Microarray, and Reverse Phase Protein Microarray</title>
            <link>http://www.medworm.com/index.php?rid=3391663&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, BREAST CANCER. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3391663</comments>
            <pubDate>Mon, 22 Mar 2010 16:20:00 +0100</pubDate>
            <guid isPermaLink="false">3391663</guid>        </item>
        <item>
            <title>A Phase I Open Label, Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation Study in SF1126, a PI Kinase (PI3K) Inhibitor, Given Twice Weekly by IV Infusion to Patients With Advanced or Metastatic Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=3085957&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085957</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085957</guid>        </item>
        <item>
            <title>A Phase 1 Study of SCH 900105 Administered by IV Infusion + Erlotinib in Advanced Solid Tumors or Lymphomas</title>
            <link>http://www.medworm.com/index.php?rid=3085956&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085956</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085956</guid>        </item>
        <item>
            <title>A Multi-Center Phase 1, Dose-Escalation Trial to Determine the Safety and Pharmacokinetics/Pharmacodynamics of RDEA119, a MEK Inhibitor, in Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=3085955&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085955</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085955</guid>        </item>
        <item>
            <title>A Phase I Trial of Oral PX-478 (a HIF-1  Inhibitor) in Patients with Advanced Solid Tumors or Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=3085954&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085954</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085954</guid>        </item>
        <item>
            <title>A Phase I-Multi-Center, Open Label, Dose Escalation, Safety, Pharmacodynamic and Pharmacokinetic Study of PRLX93936 Administered Intravenously Daily for Five Days Followed by a 23 Day Rest Period in Patients With Advanced Solid Tumor</title>
            <link>http://www.medworm.com/index.php?rid=3085953&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085953</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085953</guid>        </item>
        <item>
            <title>A Phase I Study to Assess Safety, Pharmacakinetics, and Pharmacodynmaics of PLX3397 in Patients with Advanced, Incurable, Solid Tumor or Hematologic Malignancies in which the Target Kinases are linked to Disease Pathophysiology</title>
            <link>http://www.medworm.com/index.php?rid=3085952&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085952</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085952</guid>        </item>
        <item>
            <title>A Phase II Study of oral PHA-848125AC I patients with Thymic Carcinoma Previously treated with chemotherapy</title>
            <link>http://www.medworm.com/index.php?rid=3085951&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085951</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085951</guid>        </item>
        <item>
            <title>A Phase I Dose-Escalation Study of Bruton’s Tyrosine Kinase (Btk) Inhibitor PCI-32765 in Recurrent B Cell Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=3085950&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085950</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085950</guid>        </item>
        <item>
            <title>A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of OSI-906 in Patients with Locally Advanced or Metastatic Adrenocortical Carcinoma</title>
            <link>http://www.medworm.com/index.php?rid=3085948&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085948</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085948</guid>        </item>
        <item>
            <title>A Phase 2 Dose Escalation Study of NMS-1286937 Administered to Adult Patients with Advanced/Metastatic Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=3085947&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085947</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085947</guid>        </item>
        <item>
            <title>A Phase I Dose Escalation Study of NKP-1339 in Patients with Advanced Solid Tumors Refractory to Treatment</title>
            <link>http://www.medworm.com/index.php?rid=3085946&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085946</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085946</guid>        </item>
        <item>
            <title>A Phase I Open-label, Multicenter, Dose Escalation Study to Assess the Safety and Tolerability of Genx-644282 in Patients with Advanced Malignant Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=3085945&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085945</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085945</guid>        </item>
        <item>
            <title>A Phase I, Multi-center, Open-label, Dose-escalation, Safety, Pharmacodynamic and Pharmacokinetic Study of EP-100 Given Intravenously 3 out of 4 weeks in Subject with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=3085944&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085944</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085944</guid>        </item>
        <item>
            <title>A Phase I, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynmaic Study of E6201 Administered Once Weekly for 3 Weeks (days 1, 8, and 15 of a 28-day Cycle) in Subjects with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=3085943&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085943</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085943</guid>        </item>
        <item>
            <title>An Assessment of the Effect of Food and Antacid on BIIB021 Pharmacokinetics in Subjects With Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=3085942&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085942</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085942</guid>        </item>
        <item>
            <title>A Phase I Study of AR-12 in Adult Patients with Advanced or Recurrent Solid Tumors or Lymphoma, for Which No standard Therapy is Available</title>
            <link>http://www.medworm.com/index.php?rid=3085941&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085941</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085941</guid>        </item>
        <item>
            <title>A Randomized Phase III Study of Weekly ABI-007 plus Gemcitabine versus Gemcitabine Alone in Patients with Metastatic Adenocarcinoma of the Pancreas</title>
            <link>http://www.medworm.com/index.php?rid=3085940&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085940</comments>
            <pubDate>Mon, 14 Dec 2009 18:20:00 +0100</pubDate>
            <guid isPermaLink="false">3085940</guid>        </item>
        <item>
            <title>A Phase II Study of Coagulation Factor VIIA Inhibitor PCI-27483 In Pancreatic Cancer Patients</title>
            <link>http://www.medworm.com/index.php?rid=3085949&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3085949</comments>
            <pubDate>Tue, 16 Jun 2009 19:29:00 +0100</pubDate>
            <guid isPermaLink="false">3085949</guid>        </item>
        <item>
            <title>A Phase I, multicenter, Open-label, Dose-Escalation, Safety, Pharmacodynamic, and Pharmacokinetic Study of PEGPH20 (PEGylated Recombinant Human Hyaluronidase) Given Intravenously to Patients with Advanced Solid Tumor</title>
            <link>http://www.medworm.com/index.php?rid=2486184&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486184</comments>
            <pubDate>Tue, 16 Jun 2009 19:29:00 +0100</pubDate>
            <guid isPermaLink="false">2486184</guid>        </item>
        <item>
            <title>A multicenter, Open Label, Randomized phase 2 Study to Evaluate the  Efficacy and Safety of NKTR-102 (Peg Irinotecan) Versus Irinotecan in Patients with Second Line, Irinotecan Naïve, KRAS mutant, Colorectal Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2486183&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486183</comments>
            <pubDate>Tue, 16 Jun 2009 19:29:00 +0100</pubDate>
            <guid isPermaLink="false">2486183</guid>        </item>
        <item>
            <title>A Dose- Escalation Study to Evaluate the Safety, Tolerability, and Pharmacology of VTX-2337 When Administered to Adult Subjects With Solid Tumors or Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=2486186&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486186</comments>
            <pubDate>Wed, 01 Apr 2009 19:29:00 +0100</pubDate>
            <guid isPermaLink="false">2486186</guid>        </item>
        <item>
            <title>A Phase 1 Dose Escalation Study of TAK 901 in Subjects with Advanced Hematologic Malignancies</title>
            <link>http://www.medworm.com/index.php?rid=2486185&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486185</comments>
            <pubDate>Wed, 01 Apr 2009 19:29:00 +0100</pubDate>
            <guid isPermaLink="false">2486185</guid>        </item>
        <item>
            <title>A Phase 1/Randomized Phase 2 Study to Evaluate LY2603618 in Combination with Gemcitabine in Patients with Pancreatic Cancer</title>
            <link>http://www.medworm.com/index.php?rid=2486182&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486182</comments>
            <pubDate>Wed, 01 Apr 2009 19:29:00 +0100</pubDate>
            <guid isPermaLink="false">2486182</guid>        </item>
        <item>
            <title>A Phase 1 Dose Escalation Study of ARQ 621 in Adult Patients with Metastatic Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=2486181&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2486181</comments>
            <pubDate>Wed, 01 Apr 2009 19:29:00 +0100</pubDate>
            <guid isPermaLink="false">2486181</guid>        </item>
        <item>
            <title>A Dose-Escalation Study to Evaluate the Safety, Tolerability, and Pharmacology of VTX-2337 When Administered to Adult Subjects With Solid Tumors or Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=2042715&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=2042715</comments>
            <pubDate>Tue, 16 Dec 2008 08:00:25 +0100</pubDate>
            <guid isPermaLink="false">2042715</guid>        </item>
        <item>
            <title>A Phase 1 Study of IPI-926 in patients with advanced and/or metastatic solid tumor malignancies</title>
            <link>http://www.medworm.com/index.php?rid=1909317&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909317</comments>
            <pubDate>Fri, 10 Oct 2008 08:00:30 +0100</pubDate>
            <guid isPermaLink="false">1909317</guid>        </item>
        <item>
            <title>A Phase 1 Study of SCH 900105 Administered by IV Infusion in Advanced Solid Tumors or Lymphomas</title>
            <link>http://www.medworm.com/index.php?rid=1909316&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909316</comments>
            <pubDate>Thu, 09 Oct 2008 08:00:29 +0100</pubDate>
            <guid isPermaLink="false">1909316</guid>        </item>
        <item>
            <title>A Phase 1, Multicenter, Open-Label, Dose Escalation Trial of PDL192 in Subjects with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=1909315&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909315</comments>
            <pubDate>Wed, 08 Oct 2008 08:00:28 +0100</pubDate>
            <guid isPermaLink="false">1909315</guid>        </item>
        <item>
            <title>A Phase I, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 Administered Once Weekly for 3 Weeks (days 1, 8, and 15 of a 28-day Cycle) in Subjects with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=1909314&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909314</comments>
            <pubDate>Tue, 07 Oct 2008 08:00:27 +0100</pubDate>
            <guid isPermaLink="false">1909314</guid>        </item>
        <item>
            <title>A Phase I, Multi-center, Open-Label, Dose-Escalation, safety, Pharmacokinetic, and Pharmacodynamic Study of UNBS5162 Administered IV Weekly for Three Weeks and Repeated Every Four Weeks to Patients with Advanced Solid Tumors or Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=1909313&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909313</comments>
            <pubDate>Mon, 06 Oct 2008 08:00:26 +0100</pubDate>
            <guid isPermaLink="false">1909313</guid>        </item>
        <item>
            <title>A Phase Ib Trial of PX-12 Administered as a 72-hr Infusion Every 21 Days in Patients with a Histologically or Cytologically Confirmed Diagnosis of Advanced or Metastatic cancer that is Refractory to Standard Therapy</title>
            <link>http://www.medworm.com/index.php?rid=1909312&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909312</comments>
            <pubDate>Sun, 05 Oct 2008 08:00:25 +0100</pubDate>
            <guid isPermaLink="false">1909312</guid>        </item>
        <item>
            <title>An open label phase 1 dose finding study of TRC102 in combination with pemetrexed in patients with advanced or metastatic solid cancer for whom curative therapy is unavailable</title>
            <link>http://www.medworm.com/index.php?rid=1909311&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909311</comments>
            <pubDate>Sat, 04 Oct 2008 08:00:24 +0100</pubDate>
            <guid isPermaLink="false">1909311</guid>        </item>
        <item>
            <title>A Dose Escalation Study Evaluating MK-1775 in Both Monotherapy and in combination with either Gemcitabine, Cisplatin or Carboplatin in Adult Patients with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=1909310&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909310</comments>
            <pubDate>Fri, 03 Oct 2008 08:00:23 +0100</pubDate>
            <guid isPermaLink="false">1909310</guid>        </item>
        <item>
            <title>A Phase I Study of Liposome Entrapped Docetaxel (LE-DT) in Patients with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=1909309&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909309</comments>
            <pubDate>Thu, 02 Oct 2008 08:00:22 +0100</pubDate>
            <guid isPermaLink="false">1909309</guid>        </item>
        <item>
            <title>A Phase I Study of IPI-504 and Docetaxel in Patients with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=1909308&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909308</comments>
            <pubDate>Wed, 01 Oct 2008 08:00:21 +0100</pubDate>
            <guid isPermaLink="false">1909308</guid>        </item>
        <item>
            <title>Multicenter, Open-label, Phase 2 study of NKTR-102 in combination with Cetuximab for patients with Metastatic or Locally Advanced Disease</title>
            <link>http://www.medworm.com/index.php?rid=1909307&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909307</comments>
            <pubDate>Tue, 30 Sep 2008 08:00:20 +0100</pubDate>
            <guid isPermaLink="false">1909307</guid>        </item>
        <item>
            <title>A Phase I Dose-Escalation Study of LY2495655, an Anti-Myostatin Monoclonal Antibody, in Patients with Advanced Cancer</title>
            <link>http://www.medworm.com/index.php?rid=1909306&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909306</comments>
            <pubDate>Mon, 29 Sep 2008 08:00:19 +0100</pubDate>
            <guid isPermaLink="false">1909306</guid>        </item>
        <item>
            <title>A Multi-Center Phase 1, Dose-Escalation Trial to Determine the Safety and Pharmacokinetics/Pharmacodynamics of RDEA119, a MEK Inhibitor, in Advance Cancer Patients</title>
            <link>http://www.medworm.com/index.php?rid=1909305&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909305</comments>
            <pubDate>Sun, 28 Sep 2008 08:00:18 +0100</pubDate>
            <guid isPermaLink="false">1909305</guid>        </item>
        <item>
            <title>An Open-Label, Phase I, Dose-Escalation Study of PI3 Kinase Inhibitor (GDC-0941) in Patients with Locally Advanced or Metastatic Solid Tumors for Which Standard Therapy Either Does Not Exist or Has Proven Ineffective or Intolerable</title>
            <link>http://www.medworm.com/index.php?rid=1909304&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909304</comments>
            <pubDate>Sat, 27 Sep 2008 08:00:17 +0100</pubDate>
            <guid isPermaLink="false">1909304</guid>        </item>
        <item>
            <title>A Phase I-Multi-Center, Open Label, Dose Escalation, Safety, Pharmacodynamic and Pharmacokinetic Study of PRLX 93936 Administered Intravenously Daily for Five Days Followed by a 23 Day Rest Period in Patients With Advanced Solid Tumor</title>
            <link>http://www.medworm.com/index.php?rid=1909303&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909303</comments>
            <pubDate>Fri, 26 Sep 2008 08:00:16 +0100</pubDate>
            <guid isPermaLink="false">1909303</guid>        </item>
        <item>
            <title>A Phase I Trial of Oral PX-478 (a HIF-1a Inhibitor) in Patients with Advanced Solid Tumors or Lymphoma</title>
            <link>http://www.medworm.com/index.php?rid=1909302&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909302</comments>
            <pubDate>Thu, 25 Sep 2008 08:00:15 +0100</pubDate>
            <guid isPermaLink="false">1909302</guid>        </item>
        <item>
            <title>A Phase I, Multi-Center, Open-Label, Dose-Escalation Study of the Safety, Pharmacokinetics and Anti-Tumor Activity of TH-302 in Patients with Advances Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=1909301&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909301</comments>
            <pubDate>Wed, 24 Sep 2008 08:00:14 +0100</pubDate>
            <guid isPermaLink="false">1909301</guid>        </item>
        <item>
            <title>Phase I Study of Terameprocol (EM-1421), A Survivin and Cyclin-Dependent-Kinase-1 (Cdc2) Inhibitor, in Patients with Leukemia</title>
            <link>http://www.medworm.com/index.php?rid=1909300&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909300</comments>
            <pubDate>Tue, 23 Sep 2008 08:00:13 +0100</pubDate>
            <guid isPermaLink="false">1909300</guid>        </item>
        <item>
            <title>A Safety Study to Determine the Maximum Tolerated Dose, Pharmacokinetic, Pharmacodynamics of Oral MP-470, A Multitargeted Tyrosine Kinase Inhibitor, in Patients with Solid Malignancies</title>
            <link>http://www.medworm.com/index.php?rid=1909299&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909299</comments>
            <pubDate>Mon, 22 Sep 2008 08:00:12 +0100</pubDate>
            <guid isPermaLink="false">1909299</guid>        </item>
        <item>
            <title>A Phase 1, Open-label, Dose-escalation Study of the Safety and Pharmacokinetics of SNX 5422 Mesylate in Subjects with Refractory Solid Tumor Malignancies</title>
            <link>http://www.medworm.com/index.php?rid=1909298&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909298</comments>
            <pubDate>Sun, 21 Sep 2008 08:00:11 +0100</pubDate>
            <guid isPermaLink="false">1909298</guid>        </item>
        <item>
            <title>A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Intravenous XMT-1001 in Patients With Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=1909297&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909297</comments>
            <pubDate>Sat, 20 Sep 2008 08:00:10 +0100</pubDate>
            <guid isPermaLink="false">1909297</guid>        </item>
        <item>
            <title>A Phase Ib, Multi-center, Dose Escalation Trial Of Intravenous PR-104 Given In Combination With Docetaxel Or Gemcitabine In Subjects With Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=1909296&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909296</comments>
            <pubDate>Fri, 19 Sep 2008 08:00:09 +0100</pubDate>
            <guid isPermaLink="false">1909296</guid>        </item>
        <item>
            <title>A Phase I Open Label, Safety, Pharmacokinetic and Pharmacodynamic Dose Escalation Study in SF1126, a PI Kinase (PI3K) Inhibitor, Given Twice Weekly by IV Infusion to Patients With Advanced or Metastatic Tumors</title>
            <link>http://www.medworm.com/index.php?rid=1909295&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909295</comments>
            <pubDate>Thu, 18 Sep 2008 08:00:08 +0100</pubDate>
            <guid isPermaLink="false">1909295</guid>        </item>
        <item>
            <title>An Open-Label, Phase I Study of a Hedgehog Pathway Antagonist, GDC-0449, in Patients with Locally Advanced Or Metastatic Solid Tumors That are Refractory to Standard Therapy of for Whom No Standard Therapy Exists</title>
            <link>http://www.medworm.com/index.php?rid=1909294&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909294</comments>
            <pubDate>Wed, 17 Sep 2008 08:00:07 +0100</pubDate>
            <guid isPermaLink="false">1909294</guid>        </item>
        <item>
            <title>A Phase I Dose-Escalation Study to Examine the Safety and Tolerability of IC83 Administered 1 Day After Pemetrexed 500mg/m2 Every 21 Days In Patients with Cancer</title>
            <link>http://www.medworm.com/index.php?rid=1909293&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909293</comments>
            <pubDate>Tue, 16 Sep 2008 08:00:06 +0100</pubDate>
            <guid isPermaLink="false">1909293</guid>        </item>
        <item>
            <title>A First in Man Phase I Study of EPC2407, a Microtubule Inhibitor Anti-Cancer Drug with Tumor Vascular Endothelial Disrupting Activity: Intravenous Administration Daily for Three Days in Patients with Advanced Solid Tumors and Lymphomas</title>
            <link>http://www.medworm.com/index.php?rid=1909292&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909292</comments>
            <pubDate>Mon, 15 Sep 2008 08:00:05 +0100</pubDate>
            <guid isPermaLink="false">1909292</guid>        </item>
        <item>
            <title>A Multi-center, Phase 1, Open-Label, Dose-Escalation Study to Assess the Safety, Tolerability, and Pharmacokinetics of NKT-10002 in Subjects With Refractory Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=1909291&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909291</comments>
            <pubDate>Sun, 14 Sep 2008 08:00:04 +0100</pubDate>
            <guid isPermaLink="false">1909291</guid>        </item>
        <item>
            <title>A Randomized Phase II Open-Label Study of Two Different Dose Levels of PX.-12 in Patients with Advanced Carcinoma of the Pancreas Whose Tumors Have Progressed on Gemcitabine or on a Gemcitabine-Containing Combination</title>
            <link>http://www.medworm.com/index.php?rid=1909290&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909290</comments>
            <pubDate>Sat, 13 Sep 2008 08:00:03 +0100</pubDate>
            <guid isPermaLink="false">1909290</guid>        </item>
        <item>
            <title>Phase I Clinical and Pharmacokinetic Study of CBP501 and cisplatin every 3 weeks in patients with advanced refractory solid tumors - 06-01</title>
            <link>http://www.medworm.com/index.php?rid=1909289&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909289</comments>
            <pubDate>Fri, 12 Sep 2008 08:00:02 +0100</pubDate>
            <guid isPermaLink="false">1909289</guid>        </item>
        <item>
            <title>A Pilot Study Utilizing Molecular Profiling of Patients' Tumors to Find Potential Targets and Select Treatments for Their Refractory Cancers</title>
            <link>http://www.medworm.com/index.php?rid=1909288&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=1909288</comments>
            <pubDate>Thu, 11 Sep 2008 08:00:01 +0100</pubDate>
            <guid isPermaLink="false">1909288</guid>        </item>
        <item>
            <title>Stand Up to Cancer: Phase II Study of Therapy Selected by Molecular/Metabolic Profiling in Patients with Previously Treated Metastatic Pancreatic Cancer</title>
            <link>http://www.medworm.com/index.php?rid=3974227&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, PANCREATIC CANCER. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3974227</comments>
            <pubDate>Thu, 01 Jan 1970 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3974227</guid>        </item>
        <item>
            <title>Stand Up to Cancer: Phase II Study of Gemcitabine and nab-Paclitaxel in Combination with GDC-0449 (Hedgehog Inhibitor) in patient with Previously Untreated Metastatic Adenocarcinoma of the Pancreas</title>
            <link>http://www.medworm.com/index.php?rid=3974226&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, PANCREATIC CANCER. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3974226</comments>
            <pubDate>Thu, 01 Jan 1970 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3974226</guid>        </item>
        <item>
            <title>A Phase I Study to Assess Safety, Pharmacakinetics, and Pharmacodynmaics of  PLX3397 in Patients with Advanced, Incurable, Solid Tumor or Hematologic Malignancies in which the Target Kinases are linked to Disease Pathophysiology</title>
            <link>http://www.medworm.com/index.php?rid=3974225&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, HODGKINS. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3974225</comments>
            <pubDate>Thu, 01 Jan 1970 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3974225</guid>        </item>
        <item>
            <title>A Phase I, Multi-center, Open-label, Dose-escalation, Safety, Pharmacodynamic and  Pharmacokinetic Study of EP-100 Given Intravenously 3 out of 4 weeks in Subject with Advanced Solid Tumors</title>
            <link>http://www.medworm.com/index.php?rid=3974224&amp;cid=s_38127_6_f&amp;fid=38127&amp;url=http%3A%2F%2Fwww.tgen.org%2Fresearch%2Findex.cfm%3Fpageid%3D1085</link>
            <description>TCRS Clinical Trials, BREAST CANCER. TCRS is one of the leading centers for Phase I oncology trials in the nation. Clinical trials with agents directed at specific targets in patients' tumors were launched in November 2005. These clinical trials give options that did not exist before to Phoenix-area patients as well as patients from all over the country. TCRS is conducting clinical trials across a number of cancer types... (Source: TGen TCRS Clinical Trials)</description>
            <author>TGen TCRS Clinical Trials</author>
            <type>clinical trials</type>
        <comments>http://www.medworm.com/rss/comments.php?id=3974224</comments>
            <pubDate>Thu, 01 Jan 1970 00:00:00 +0100</pubDate>
            <guid isPermaLink="false">3974224</guid>        </item>
    </channel>
</rss>

